The challenge of antimicrobial resistance: what economics can contribute

Roope, Laurence S. J.; Smith, Richard D.; Pouwels, Koen B.; Buchanan, James; Abel, Lucy; Eibich, Peter; Butler, Christoph C.; Tan, Pui San; Walker, A. Sarah; Robotham, Julie V.; Wordsworth, Sarah

doi:10.1126/science.aau4679

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The challenge of antimicrobial resistance: what economics can contribute

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Roope, L. S. J., Smith, R. D., Pouwels, K. B., Buchanan, J., Abel, L., Eibich, P., et al. (2019). The challenge of antimicrobial resistance: what economics can contribute. Science, 364(6435), e4679-e4679. doi:10.1126/science.aau4679.

Cite as: https://hdl.handle.net/21.11116/0000-0006-B05E-A

Abstract

As antibiotic consumption grows, bacteria are becoming increasingly resistant to treatment. Antibiotic resistance undermines much of modern health care, which relies on access to effective antibiotics to prevent and treat infections associated with routine medical procedures. The resulting challenges have much in common with those posed by climate change, which economists have responded to with research that has informed and shaped public policy. Drawing on economic concepts such as externalities and the principal–agent relationship, we suggest how economics can help to solve the challenges arising from increasing resistance to antibiotics. We discuss solutions to the key economic issues, from incentivizing the development of effective new antibiotics to improving antibiotic stewardship through financial mechanisms and regulation.